STAT
DECEMBER 10, 2024
The Ohio Supreme Court ruled that three of the largest pharmacy chain operators in the U.S. could not be held liable under a state nuisance law for contributing to the long-running opioid crisis. In a 5-to-2 vote, the court determined that the law barred two Ohio counties from obtaining a $650.9 million judgement that was won in a federal court against CVS Health, Walgreens, and Walmart.
Pharmacy Times
DECEMBER 10, 2024
The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists value within the health care system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 10, 2024
Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major drugmaker to do so, CEO David Ricks said Tuesday. Emerging research suggests that GLP-1 drugs — Zepbound is one such treatment — not only reduce food cravings but may also suppress desires for other substances.
Drug Topics
DECEMBER 10, 2024
See whats trending in pharmacy with a preview of the Drug Topics November/December issue.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
DECEMBER 10, 2024
Cockroaches are a hardy pest, and often elicit disgust. But they do have a few things going for them: They are cheap, can be raised in a space as small as a shoebox, and aren’t dangerous to humans. That makes the insects uniquely qualified for neuroscience outreach, according to researchers trying to create low-cost tools and free computer programs that can entice students in high school and college to pursue careers in the field.
Drug Topics
DECEMBER 10, 2024
Study results show improvement in progression-free survival at 22 months.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
DECEMBER 10, 2024
A tour of modern antiretroviral and pre-exposure prophylaxis therapies included the latest updates in HIV management and prevention.
STAT
DECEMBER 10, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Let’s get to the news.
Drug Topics
DECEMBER 10, 2024
Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.
Compounding Pharmacy of America
DECEMBER 10, 2024
Learn how to optimize your health with vitamins and supplements. Discover their benefits, how to use them effectively, and tips for personalizing your supplement routine. The post How to Use Vitamins and Supplements for Optimal Health appeared first on Compounding Pharmacy of America.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
DECEMBER 10, 2024
Researchers observed the use of a discrete event simulation using non-invasive tests for patients with nonalcoholic steatohepatitis.
The Checkup by Singlecare
DECEMBER 10, 2024
Trulicity (dulaglutide) and Ozempic (semaglutide) are both brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. Because these drugs suppress appetite, some healthcare providers prescribe them off-label for weight loss. However, another medication with the same active ingredient as Ozempic has been FDA approved for weight loss and is sold under the brand name Wegovy.
Drug Topics
DECEMBER 10, 2024
Scott Biggs, director of supplier services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.
STAT
DECEMBER 10, 2024
NEW YORK — On the 77th floor of One World Trade Center, in an office with panoramic views of Manhattan, executives from pharma and biotech companies like Regeneron and Merck heard the pitch: Please help us study GLP-1s in Parkinson’s disease. With the explosion in popularity of diabetes and weight loss drugs like Ozempic and Zepbound, GLP-1 receptor agonist drugs have been hyped as potential miracle cures for many diseases.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
DECEMBER 10, 2024
A conversation with Madison Irwin, PharmD, BCPS, clinical pharmacist specialist in palliative care at University of Michigan Health and a clinical assistant professor at the University of Michigan College of Pharmacy.
STAT
DECEMBER 10, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I’m back from my three-week vacation. No big news happened while I was gone, right?
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
DECEMBER 10, 2024
Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.
Drug Topics
DECEMBER 10, 2024
The effectiveness of remdesivir was consistent among patients who received any form of supplemental oxygen and across all age groups in the study.
PharmaVoice
DECEMBER 10, 2024
Pharmacy Times
DECEMBER 10, 2024
Pharmacists play a crucial role in promoting the appropriate use of broad-spectrum antibiotics to prevent antimicrobial resistance and improve patient outcomes.
Pharmacy Times
DECEMBER 10, 2024
This builds off prior data that showed safety and efficacy of CD19 and CD22 chimeric antigen receptor (CAR)-T cell therapy in children with relapsed or refractory B-lineage acute lymphoblastic leukemia (B-ALL).
STAT
DECEMBER 10, 2024
This roundup of news from the ASH 2024 conference first appeared in STAT’s “ASH in 30” newsletter. Is it Tuesday already? This is the last day of the American Society of Hematology meeting. Thanks for stopping by to read all of our coverage. San Diego has been a wonderful host city, and we look forward to being in Orlando next December.
Fierce Pharma
DECEMBER 10, 2024
Pharmacy Times
DECEMBER 10, 2024
Navtemadlin has demonstrated meaningful efficacy and safety as a monotherapy or combination treatment in various preclinical and clinical trials.
Pharmaceutical Technology
DECEMBER 10, 2024
While 88.
Pharmacy Times
DECEMBER 10, 2024
Results suggest that patients commonly receive more than 5 days of treatment, which could be an opportunity for an antimicrobial stewardship initiative.
Pharmafile
DECEMBER 10, 2024
BASINGSTOKE, 5th December 2024 Eli Lilly and Company announced today that the National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending tirzepatide as an option for managing overweight and obesity, alongside a reduced-calorie diet and increased physical activity, in adults with an initial Body Mass Index (BMI) of at […] The post NICE RECOMMENDS LILLYS TIRZEPATIDE (MOUNJARO ) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE appeared
Expert insights. Personalized for you.
140 
Let's personalize your content